Wikipedia:WikiProject Chemicals/Chembox validation/VerifiedDataSandbox and Oxaprotiline: Difference between pages
(Difference between pages)
Content deleted Content added
Saving copy of the {{drugbox}} taken from revid 455664971 of page Oxaprotiline for the Chem/Drugbox validation project (updated: 'ChEMBL', 'CAS_number'). |
CrafterNova (talk | contribs) citation tweak |
||
Line 1: | Line 1: | ||
{{Short description|Chemical compound}} |
|||
{{ambox | text = This page contains a copy of the infobox ({{tl|drugbox}}) taken from revid [{{fullurl:Oxaprotiline|oldid=455664971}} 455664971] of page [[Oxaprotiline]] with values updated to verified values.}} |
|||
{{Drugbox |
{{Drugbox |
||
| Verifiedfields = changed |
|||
⚫ | |||
| Watchedfields = changed |
|||
⚫ | |||
| IUPAC_name = (±)-3-(9,10-ethano-9,10-dihydro-9-anthryl)-1-methylamino-2-propanol |
| IUPAC_name = (±)-3-(9,10-ethano-9,10-dihydro-9-anthryl)-1-methylamino-2-propanol |
||
| image = Oxaprotiline.svg |
| image = Oxaprotiline.svg |
||
<!--Clinical data--> |
<!--Clinical data--> |
||
| tradename = |
| tradename = |
||
| pregnancy_category = |
| pregnancy_category = |
||
| legal_status = Uncontrolled |
| legal_status = Uncontrolled |
||
| routes_of_administration = Oral |
| routes_of_administration = [[Oral administration|Oral]] |
||
<!--Pharmacokinetic data--> |
<!--Pharmacokinetic data--> |
||
| bioavailability = |
| bioavailability = |
||
| protein_bound = |
| protein_bound = |
||
| metabolism = |
| metabolism = |
||
| elimination_half-life = |
| elimination_half-life = |
||
| excretion = |
| excretion = |
||
<!--Identifiers--> |
<!--Identifiers--> |
||
| CAS_number_Ref = {{cascite|changed|??}} |
|||
| CAS_number = |
| CAS_number = 56433-44-4 |
||
| ATC_prefix = |
|||
| |
| ATC_prefix = |
||
| ATC_suffix = |
|||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
||
| StdInChI = 1S/C20H23NO/c1-21-13-14(22)12-20-11-10-15(16-6-2-4-8-18(16)20)17-7-3-5-9-19(17)20/h2-9,14-15,21-22H,10-13H2,1H3 |
| StdInChI = 1S/C20H23NO/c1-21-13-14(22)12-20-11-10-15(16-6-2-4-8-18(16)20)17-7-3-5-9-19(17)20/h2-9,14-15,21-22H,10-13H2,1H3 |
||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
||
| StdInChIKey = FDXQKWSTUZCCTM-UHFFFAOYSA-N |
| StdInChIKey = FDXQKWSTUZCCTM-UHFFFAOYSA-N |
||
| ChEMBL_Ref = {{ebicite|correct|EBI}} |
|||
| ChEMBL = 1213009 |
| ChEMBL = 1213009 |
||
| PubChem = 38207 |
| PubChem = 38207 |
||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
||
| DrugBank = |
| DrugBank = |
||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
||
| ChemSpiderID = 35026 |
| ChemSpiderID = 35026 |
||
Line 36: | Line 40: | ||
<!--Chemical data--> |
<!--Chemical data--> |
||
| C=20 | H=23 | N=1 | O=1 |
|||
| chemical_formula = C<sub>20</sub>H<sub>23</sub>NO |
|||
⚫ | |||
}} |
|||
'''Oxaprotiline''' (developmental code name '''C 49-802 BDA'''), also known as '''hydroxymaprotiline''', is a [[norepinephrine reuptake inhibitor]] belonging to the [[tetracyclic antidepressant]] (TeCA) family and is related to [[maprotiline]]. Though investigated as an [[antidepressant]],<ref>{{cite journal |vauthors=Giedke H, Gaertner H, Breyer-Pfaff U, Rein W, Axmann D | title = Amitriptyline and oxaprotiline in the treatment of hospitalized depressive patients. Clinical aspects, psychophysiology, and drug plasma levels | url = https://pubmed.ncbi.nlm.nih.gov/3527706/| journal = European Archives of Psychiatry and Neurological Sciences | year = 1986 | volume = 235 | issue = 6 | pages = 329–338 | pmid = 3527706 | doi=10.1007/bf00381001| s2cid = 24152419 }}</ref> it was never marketed. |
|||
| molecular_weight = 293.40 g/mol |
|||
⚫ | |||
==Pharmacology== |
|||
Dextroprotiline acts as a [[potency (pharmacology)|potent]] [[norepinephrine reuptake inhibitor]]<ref name="pmid7115436">{{cite journal |vauthors=Waldmeier PC, Baumann PA, Hauser K, Maitre L, Storni A | title = Oxaprotiline, a noradrenaline uptake inhibitor with an active and an inactive enantiomer | journal = [[Biochemical Pharmacology (journal)|Biochemical Pharmacology]] | volume = 31 | issue = 12 | pages = 2169–76 |date=June 1982 | pmid = 7115436 | doi = 10.1016/0006-2952(82)90510-X}}</ref><ref name="pmid8382162">{{cite journal |vauthors=Reimann IW, Firkusny L, Antonin KH, Bieck PR | title = Oxaprotiline: enantioselective noradrenaline uptake inhibition indicated by intravenous amine pressor tests but not alpha 2-adrenoceptor binding to intact platelets in man | journal = European Journal of Clinical Pharmacology | volume = 44 | issue = 1 | pages = 93–5 | year = 1993 | pmid = 8382162 | doi = 10.1007/BF00315288| s2cid = 22691825 }}</ref> and [[H1 receptor|H<sub>1</sub> receptor]] [[receptor antagonist|antagonist]],<ref name="pmid1353628">{{cite journal |vauthors=Noguchi S, Inukai T, Kuno T, Tanaka C | title = The suppression of olfactory bulbectomy-induced muricide by antidepressants and antihistamines via histamine H1 receptor blocking | journal = Physiology & Behavior | volume = 51 | issue = 6 | pages = 1123–7 |date=June 1992 | pmid = 1353628 | doi = 10.1016/0031-9384(92)90297-F| s2cid = 29562845 }}</ref> as well as a very weak [[a1-adrenergic receptor|α<sub>1</sub>-adrenergic receptor]] [[receptor antagonist|antagonist]].<ref name="pmid7115436" /><ref name="pmid6086881">{{cite journal |vauthors=Richelson E, Nelson A | title = Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro | journal = The Journal of Pharmacology and Experimental Therapeutics | volume = 230 | issue = 1 | pages = 94–102 |date=July 1984 | pmid = 6086881 | url = http://jpet.aspetjournals.org/cgi/pmidlookup?view=long&pmid=6086881}}</ref> It has negligible [[affinity (pharmacology)|affinity]] for the [[serotonin transporter]],<ref name="pmid7115436" /> [[dopamine transporter]], [[a2-adrenergic receptor|α<sub>2</sub>-adrenergic receptor]],<ref name="pmid7115436" /><ref name="pmid6086881" /> and [[muscarinic acetylcholine receptor]]s.<ref name="pmid6086881" /> Whether it has any [[receptor antagonist|antagonistic]] effects on the [[5-HT2 receptor|5-HT<sub>2</sub>]], [[5-HT7 receptor|5-HT<sub>7</sub>]], or [[D2 receptor|D<sub>2</sub> receptor]]s like its relative [[maprotiline]] is unclear. |
|||
Levoprotiline acts as a [[functional selectivity|selective]] [[H1 receptor|H<sub>1</sub> receptor]] [[receptor antagonist|antagonist]], with no affinity for [[adrenergic receptor|adrenaline]], [[dopamine receptor|dopamine]], [[muscarinic acetylcholine receptor|muscarinic acetylcholine]], or [[serotonin receptor|serotonin]] [[Receptor (biochemistry)|receptors]], or any of the [[monoamine transporter]]s.<ref name="pmid7115436" /><ref name="pmid8382162" /><ref name="pmid1353628" /> |
|||
==Chemistry== |
|||
Oxaprotiline is a [[racemic]] compound composed of two [[isomer]]s, ''R''(−)- or [[Levorotation|levo]]- oxaprotiline ('''levoprotiline'''; '''CGP-12,103-A'''), and ''S''(+)- or dextro- oxaprotiline ('''dextroprotiline'''; '''CGP-12,104-A'''). Both enantiomers are active, with the levo- form acting as an [[antihistamine]] and the dextro- form having an additional pharmacology (see [[Oxaprotiline#Pharmacology|above]]), but with both unexpectedly still retaining antidepressant effects.<ref name="pmid1530672">{{cite journal |vauthors=Noguchi S, Fukuda Y, Inukai T | title = Possible contributory role of the central histaminergic system in the forced swimming model | journal = Arzneimittel-Forschung | volume = 42 | issue = 5 | pages = 611–3 |date=May 1992 | pmid = 1530672 }}</ref> |
|||
==See also== |
|||
* [[Maprotiline]] |
|||
==References== |
|||
{{Reflist|2}} |
|||
{{Antidepressants}} |
|||
{{Navboxes |
|||
| title = [[Pharmacodynamics]] |
|||
| titlestyle = background:#ccccff |
|||
| list1 = |
|||
{{Adrenergic receptor modulators}} |
|||
{{Histamine receptor modulators}} |
|||
{{Monoamine reuptake inhibitors}} |
|||
}} |
}} |
||
{{Tricyclics}} |
|||
[[Category:Secondary alcohols]] |
|||
[[Category:Amines]] |
|||
[[Category:Anthracenes]] |
|||
[[Category:Tetracyclic antidepressants]] |